StonvexLoading…
StonvexStonvexStonvexCore line items from DRVN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 | Q1 2025 2025-03-29 | Annual 2024 2024-12-28 |
|---|---|---|---|---|
Revenue | $1.60B | $1.07B | $516.16M | $2.34B |
Operating Income | $161.31M | $99.38M | $61.27M | $-140.23M |
Net Income | $113.93M | $53.07M | $5.51M | $-292.50M |
EPS (Diluted) | $0.69 | $0.33 | $0.04 | $-1.82 |
Total Assets | $4.15B | $4.28B | $5.30B | $5.26B |
Total Liabilities | $3.36B | $3.54B | $4.66B | $4.65B |
Cash & Equivalents | $162.03M | $166.13M | $152.04M | $149.57M |
Free Cash Flow OCF − CapEx | $67.36M | $27.91M | $18.90M | $-47.06M |
Shares Outstanding | 164.45M | 164.27M | 164.27M | 163.84M |